Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Parecoxib

Parecoxib

Parecoxib structure

Parecoxib 

structure
  • CAS No:

    198470-84-7

  • Formula:

    C19H18N2O4S

  • Chemical Name:

    Parecoxib

  • Synonyms:

    Propanamide,N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-;N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide;Parecoxib;SC 69124;Vorth-P;Valus-P;Xapit

  • Categories:

    Active Pharmaceutical Ingredients  >  Antipyretic Analgesics

Description

ChEBI: An N-acylsulfonamide resulting from the formal condensation of valdecoxib with propionic acid. It is a prodrug for valdecoxib.


Parecoxib is an N-acylsulfonamide resulting from the formal condensation of valdecoxib with propionic acid. It is a prodrug for valdecoxib. It has a role as a cyclooxygenase 2 inhibitor, a non-narcotic analgesic, a non-steroidal anti-inflammatory drug and a prodrug. It is a member of isoxazoles and a N-sulfonylcarboxamide. It derives from a valdecoxib.|Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac (Toradol) is used in the United States. A letter of non-approval for parecoxib was issued by the FDA in 2005.|Parecoxib is an amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, with anti-inflammatory, analgesic, and antipyretic activities. Upon administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and, therefore, does not interfere with blood coagulation.

Parecoxib Basic Attributes

370.423

370.42

1308068-626-2

9TUW81Y3CE

DTXSID1044229

C66318

M01AH04|M - Musculo-skeletal system

Characteristics

97.6

3.3

1.264

148.9-151°

1.580

189.2 Ų [M+H]+ [CCS Type: TW, Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Safety Information

NONH for all modes of transport

3

63-48/22-51/53

36/37-61

TX1478700

Xn,N

P281

H361d-H373

|Warning|H361 (95%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P260, P281, P308+P313, P314, P405, and P501|Aggregated GHS information provided by 40 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

98%

Drug Information

Used for short term perioperative pain control.|For the short-term treatment of postoperative pain in adults.,|For the short-term treatment of postoperative pain.The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of theindividual patient's overall risks (see sections 4.3, 4.4).|For the short-term treatment of postoperative pain.

A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)

Hepatic. Metabolized primarily via CYP3A4 and 2C9 to valdecoxib and propionic acid.

22 minutes (parecoxib); 8 hours (valdecoxib)

Dynastat

Parecoxib Use and Manufacturing

Methods of Manufacturing

3.1 g (10 mmol) of valdecoxib was mixed with 3.5 g (35 mmol) of triethylamine and 2.6 g (20 mmol) of propionic anhydride at 20 ° CDichloromethane, after the reaction, pour into water, dichloromethane extraction, concentration, ethanol dissolved, 5 ~ 10 crystallization, Filtering and drying to obtain 3.4g of parecoxib, the yield is 92.5percent and the purity is 99.77percentThe valdecoxib 3.1g (10mmol) and triethylamine 3.5g (35mmol) and propionic anhydride 2.6g (20mmol) were mixed in 20 Methylene chloride, after completion of the reaction, poured into water and extracted with methylene chloride, concentrated, dissolved in ethanol, 5 ~ 10 crystallization, Filtration, drying parecoxib 3.4g, yield 92.7percent, purity of 99.61percent.3.1 g (10 mmol) of valdecoxib was mixed with 3 g (30 mmol) of triethylamine, And propionic anhydride (3.3 g, 25 mmol) were mixed in dichloromethane at 20 ° C, After completion of the reaction, Dumped into the water, Dichloromethane extraction, concentrate, Ethanol dissolved, 5 ~ 10 crystallization, filter, Drying was 3.4g of parecoxib, The yield was 92.4percentPurity 99.81percent.The raw material valdecoxib III (5.0g) was added to propionic anhydride (18.6g), and stirred to dissolve.Benzene sulfonic acid (0.25g) was added, and the temperature was raised to 50 to 60 ° C and reacted for about 3 hours.TLC monitoring reaction was complete, cooled to about 0 , incubated for about 1 hour.Filter, the filter cake with methyl tert-butyl ether (10ml) was rinsed in a vacuum oven, -0.08MPa ~ -0.1MPa, vacuum dried at 50 8 to 12 hours to obtain 4.90g parecoxib sodium intermediate I, yield 83.2percent.HPLC purity of 99.93percent, the largest single miscellaneous 0.05percent, the raw material valdecoxib III

Uses

Anti-inflammatory; analgesic (cyclooxygenase COX-2 inhibitor).

Human drugs -> Dynastat -> EMA Drug Category|Coxibs, Antiinflammatory and antirheumatic products -> Human pharmacotherapeutic group|Human drugs -> Rayzon -> EMA Drug Category|Antiinflammatory and antirheumatic products -> Human pharmacotherapeutic group|Human drugs -> Xapit -> EMA Drug Category

Computed Properties

Molecular Weight:370.4
XLogP3:3.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:5
Exact Mass:370.09872823
Monoisotopic Mass:370.09872823
Topological Polar Surface Area:97.6
Heavy Atom Count:26
Complexity:575
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Parecoxib

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.